"Our core mission is to contribute to global health by providing new innovative vaccines overcoming the urgent medical problem of antimicrobial resistance. Utilizing our proprietary technology platform, we enable production of safe and superior immunogenic toxoid antigens for highly needed vaccines to disarm specific pathogenic bacteria without the need for non-specific antimicrobial treatment."
Proxi Biotech, 2023
All vaccines are developed by leveraging from the strength and versatility of our BACTOVAC platform
Copyright 2023 Proxi Biotech ApS All Rights Reserved